About HEC Pharm Co., Ltd.

HEC Group entered the pharmaceutical industry in 2001 by acquiring an API company in Yidu, Hubei, which had fewer than 100 employees and an annual turnover of not more than RMB 20 million. By the end of 2009, HEC Pharm employed more than 3000 skilled personnel in three GMP certified pharmaceutical companies, which have been favorably inspected by US and European authorities, and one of the largest domestic Research Institute. HEC is the third company authorized by Roche to produce the anti-H1N1 drug Oseltamivir. The corporation has six API synthesis plants, with a fermentation capacity of more than 6000 tons, and five dosage form plants producing fifteen APIs and more than thirty drug products. The marketing network covers 30 provinces in China, Europe and America. In 2009, pharmaceutical product sales turnover reached USD 500 million.

website icon
Website
employees icon
Employees
industry icon
Industry
Pharmaceuticals
location icon
Location
Zhen An Road No. 368 Chang An Town,Dongguan,Guangdong,CN
description icon
Founded
2002

HEC Pharm Co., Ltd. Alternatives

Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals

Frequently Asked Questions about HEC Pharm Co., Ltd.

Who is the CEO of HEC Pharm Co., Ltd.?

Zhi Chen is the CEO of HEC Pharm Co., Ltd.. To contact Zhi Chen email at [email protected] or [email protected].

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more